{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:15:56Z","timestamp":1791422156934,"version":"4.3.3"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OV"],"DOI":"10.2147\/ov.s66091","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T23:35:56Z","timestamp":1441928156000},"page":"133","source":"Crossref","is-referenced-by-count":4,"title":["Oncolytic virotherapy for human malignant mesothelioma: recent advances"],"prefix":"10.2147","author":[{"given":"Marc","family":"Marc Gr\u00e9goire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boisgerault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Achard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Delaunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cellerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Tangy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Fonteneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,9]]},"container-title":["Oncolytic Virotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=26989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:52:14Z","timestamp":1477867934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/oncolytic-virotherapy-for-human-malignant-mesothelioma-recent-advances-peer-reviewed-article-OV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ov.s66091","relation":{},"ISSN":["2253-1572"],"issn-type":[{"value":"2253-1572","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}